Oramed Pharmaceuticals Inc. (ORMP) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Oramed Pharmaceuticals In...

    NASDAQ: ORMP · Real-Time Price · USD
    2.44
    -0.07 (-2.93%)
    At close: Oct 03, 2025, 3:59 PM
    2.48
    1.64%
    After-hours: Oct 03, 2025, 07:11 PM EDT

    Oramed Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Aug 31, 2021
    Net Income
    		 -19.1M 5.09M -37.76M -22.99M
    Depreciation & Amortization
    		 193K 196K 58K 77K
    Stock-Based Compensation
    		 4.05M 4.21M 11.51M 2.69M
    Other Working Capital
    		 -325K -471K -567K -3.38M
    Other Non-Cash Items
    		 3.25M -17.09M -778K 1.04M
    Deferred Income Tax
    		 n/a n/a n/a -689K
    Change in Working Capital
    		 3.2M -2.7M -943K -1.31M
    Operating Cash Flow
    		 -8.41M -10.29M -27.92M -21.18M
    Capital Expenditures
    		 -18K -254K -496K -375K
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 -55.76M -190.92M -154.41M -53.82M
    Sales Maturities Of Investments
    		 161.66M 118.14M 185.09M 30.43M
    Other Investing Acitivies
    		 -65K n/a 26K -1K
    Investing Cash Flow
    		 105.82M -73.04M 30.21M -23.76M
    Debt Repayment
    		 -49.55M 49.55M n/a n/a
    Common Stock Repurchased
    		 -2.48M n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -2K n/a -721K 22.91M
    Financial Cash Flow
    		 -52.04M 51.98M 10.78M 102.89M
    Net Cash Flow
    		 45.37M -31.41M 13.01M 57.95M
    Free Cash Flow
    		 -8.43M -10.55M -28.41M -21.56M

    Add to Watchlist